Glass Lewis Endorses Sinovac’s Current Board, Urges Shareholders to Reject Former Directors’ Takeover Attempt Sinovac Biotech Ltd., a leading Chinese biopharmaceutical company, announced today that Glass Lewis, a top independent corporate governance advisory firm, has recommended that shareholders vote in…
ISS and Glass Lewis Endorse Sinovac’s Current Board Ahead of Crucial Shareholder Vote Sinovac Biotech Ltd. a leading Chinese biopharmaceutical company, announced that Institutional Shareholder Services Inc. (ISS), one of Wall Street’s most respected independent corporate governance research and proxy…
Global Sickle Cell Disease Treatment Market Poised for Robust Growth Through 2035 The global sickle cell disease (SCD) treatment market is set to witness substantial growth from 2025 to 2035, driven by increasing disease prevalence, advancements in therapeutic development, and…
Global Cancer Vaccine Market Poised for Strong Growth Through 2031, Driven by Innovation in Precision Immunotherapy and Personalized Medicine The global cancer vaccine market has experienced robust growth over recent years and is expected to continue on this trajectory, propelled…
In-Depth Report Sheds Light on Distribution Deals in the Pharma and Biotech Sectors (2020–2025) A newly updated research publication, Distribution Deals in Pharmaceuticals and Biotechnology, offers a comprehensive analysis of distribution partnerships formed within the pharmaceutical and biotechnology industries from…
Gamma Delta T Cell Therapy: A Transformative Frontier in Cancer Immunotherapy with U.S. and China Leading Global Trials Gamma delta (γδ) T cell therapy is rapidly emerging as a promising frontier in the field of cancer immunotherapy. Unlike the more…
Acadia Pharmaceuticals Grants Equity Awards to New Hires Under Nasdaq Rule 5635(c)(4) Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders…
Manitoba Bioscience Association Backs Government Plan to Boost Research and Clinical Trials Bioscience Association Manitoba (BAM) has voiced strong support for a major new initiative from the Manitoba government aimed at advancing health research and clinical trials across the province.…
Stallergenes Greer Appoints CEOLIA as New Promotional Partner for Actair® in Japan, Concluding 13-Year Collaboration with Shionogi Stallergenes Greer, a global leader in allergen immunotherapy, has announced a strategic transition in the Japanese market for its flagship product, Actair®, a…
WHO Concludes Participation in Major Global Nuclear Emergency Simulation The World Health Organization (WHO) has successfully concluded its role in a high-stakes, 36-hour nuclear emergency simulation exercise organized by the International Atomic Energy Agency (IAEA). Known as ConvEx-3, this large-scale,…
Comprehensive Report Reveals Key Trends in Gynecology Collaboration and Licensing Deals from 2016 to 2025 Gynecology Collaboration and Licensing Deals report offers a deep dive into the evolving landscape of partnerships in women’s health, providing unparalleled insights into over 150…
Synedgen Appoints Dr. Laura Saward as CEO and Dr. Kenton Gregory as CMO Amid Strategic Growth Synedgen, Inc., a biotechnology company pioneering treatments based on human glycobiology, has announced significant leadership changes as the company accelerates its clinical and strategic…
